preloader preloader preloader preloader preloader preloader preloader

BI011 - Breast MRI--DCIS and Interventions
          Christiane Kuhl, MD

Christiane Kuhl, MD
Professor and Vice-Chairman of Radiology
Section Chief, Division of Oncologic Imaging and Interventional Therapy
University of Bonn
Bonn, Germany

Objectives
At the conclusion of this presentation, the participant will be able to:
1. List the MR imaging features of DCIS
2. Identify appropriate indications for MRI of the breast in the presence of mammographic calcifications
3. List indications for MR guided vacuum biopsy
4. List indications for MR guided needle localization
5. Describe strategies of how to avoid difficulties associated with MR guided interventions

Program Format
Participant may view this video at his/her leisure.
Upon completion, participant will be tested on the content of the program.
CME evaluation form must be filled out after viewing program.
CME certificate may be printed after completion of program, test, and CME evaluation.
The estimated time to complete this program is 1 hour.
Program release date October 17, 2008
Program available for CME credit until October 17, 2011
Multi-platform FLASH based presentation
Hardware and Software Requirements (click here)

AccreditationLoma Linda University
Loma Linda University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  Loma Linda University School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The American Society of Radiologic Technologists (ASRT) has assigned 1.0 Category A continuing education (CE) credits to this programIf you are currently a Radiologic Technologist with an ARRT registration number, the ASRT is an ARRT-approved Recognized Continuing Education Evaluation Mechanism.

Faculty Disclosure
Christiane Kuhl, MD, has no commercial relationships to disclose.